Efficacy and tolerability of BP-C1 in metastatic breast cancer: a Phase II, randomized, double-blind, and placebo-controlled Thai multi-center study

Efficacy and tolerability of BP-C1 in metastatic breast cancer: a Phase II, randomized, double-blind, and placebo-controlled Thai multi-center study

Kritiya Butthongkomvong,1 Nilubol Raunroadroong,2 Sirikul Sorrarichingchai,2 Isaraporn Sangsaikae,3 Vichien Srimuninnimit,4 Henrik Harling,5 Stig Larsen6 1Udonthani Cancer Hospital, Udonthani, Thailand; 2Lampang Cancer Hospital, Lampang, Thailand; 3Ubonratchathani Cancer Hospital, Ubonratchathani, T...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Butthongkomvong K, Raunroadroong N, Sorrarichingchai S, Sangsaikae I, Srimuninnimit V, Harling H, Larsen S
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2019
Materias:
Benzene-polycarboxylic acid complex
BP-C1
low dose cisplatin
breast cancer
stage IV
hormone receptors
randomised double blind
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Acceso en línea:https://doaj.org/article/5f0834f35ca64ae8a912ce2e77fea5de
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/5f0834f35ca64ae8a912ce2e77fea5de

Ejemplares similares